Menu

Lexicon Pharmaceuticals, Inc. LXRX

Full chart Compare
Set alert

Price alert · LXRX

All alert types
1.82 USD +0.04 (+2.25%)

At closeNov 9, 2026, 7:47 PM EST

1.83 +0.01 +0.55%

After hours · Nov 9, 7:47 PM ET

1.79 Day range 1.92
1.10 52-week range 2.68
YTD
+58.26%
1 year
+45.60%

Revenue & Expenses

Revenue by
License → Revenue: $45.00MRevenue → Gross Profit: $49.53MGross Profit → Expenses: $49.53MRevenue → Cost of Revenue: $274.00KExpenses → Selling, General & Admin: $37.32MExpenses → Research & Development: $61.12MExpenses → Other Expenses: $1.43MProduct → Revenue: $4.65MNet Loss → Expenses: $50.34MGross Profit$49.53MNet Loss$50.34MCost of Revenue$274.00KExpenses$99.87MSelling, General & Admin$37.32MResearch & Development$61.12MOther Expenses$1.43MRevenue$49.80MLicense$45.00MProduct$4.65M

Latest period ending Dec 31, 2025 · select a line to chart its full history

LXRX annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
49.80M31.08M1.20M139.00K298.00K
49.53M30.46M1.12M139.00K298.00K
-48.91M-197.12M-171.75M-100.76M-87.09M
-50.34M-200.40M-177.12M-101.94M-87.76M
-0.14-0.63-0.80-0.62-0.60
LXRX annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
63.33M66.66M22.46M46.34M64.06M
184.99M298.42M229.43M194.30M136.91M
77.45M152.47M136.32M77.17M23.31M
54.00M100.30M99.51M54.00M1.19M
107.54M145.95M93.11M117.12M113.59M
LXRX annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-67.85M-178.78M-161.90M-88.85M-87.02M
113.02M-15.38M-49.94M-71.08M2.11M
-48.50M238.35M187.96M142.21M22.71M
-3.33M44.19M-23.88M-17.72M-62.20M